Table 3 Association between G6PD deficiency and 28-day follow-up PCR corrected ACT efficacy
Efficacy | Hemizygous n (%) | Heterozygous n (%) | Homozygous n (%) | Normal n (%) | Total n (%) |
|---|---|---|---|---|---|
Cured* | 20 (100) | 29 (96.6) | 3 (100.0) | 237 (98.02) | 299 (98.03) |
Failure cases | 0 (0.0) | 1 (3.33) | 0 (0.0) | 5 (1.98) | 6 (1.97) |
Total | 20 (100) | 30 (100) | 3 (100) | 252 (100) | 305 (100) |